Fish Oil.

The long-chain fats in fish oil oxidize easily, and vitamin E is a fat-soluble antioxidant that sits in the same oil phase and interrupts the chain reaction that would otherwise turn those fats rancid. Higher omega-3 intake also draws on the body's vitamin E, so the two are routinely formulated together.

Vitamin D3 is fat-soluble and relies on dietary fat to form the micelles that carry it across the gut lining, so the oil in a fish oil softgel gives it a lipid vehicle to be taken up with. Cod liver oil has delivered both in a single dose for generations for this reason.

Astaxanthin is a fat-soluble pigment and antioxidant that concentrates in the oil phase, where it helps shield the fragile omega-3 fats from oxidation, and the two co-occur naturally in krill and salmon. Being fat-soluble itself, astaxanthin is also taken up better alongside the oil.

CoQ10 is a lipophilic quinone with poor uptake from a water phase. Taken in an oil base such as fish oil it partitions into the same mixed micelles and reaches the lymphatic route more readily.

Phospholipids emulsify the oil into finer droplets, giving pancreatic lipase more surface to work on. This is long-standing practice in omega-3 emulsions and softgels.

DHA is carried in the body mainly as phosphatidylcholine, and choline supplies the head group of that molecule. Supplying both gives the membrane both halves of the same structure.

Long-chain fatty acids from fish oil cross the inner mitochondrial membrane only as acylcarnitines. Carnitine is the carrier for that step in normal fatty acid oxidation.

Glutathione peroxidase is a selenoenzyme that reduces lipid hydroperoxides. A higher intake of long-chain polyunsaturated fat raises the amount of peroxide the enzyme has to clear.

The desaturase and elongase enzymes that remodel dietary fatty acids depend on zinc status. Low zinc slows that same conversion pathway.

Lutein is absorbed only when packaged into micelles with dietary fat. Dosing it alongside an oil raises the fraction that reaches the bloodstream.

Rosemary diterpenes are the standard oil-phase antioxidant used to hold back peroxidation of marine oils during shelf life. It protects the ingredient itself rather than acting in the body.

Tocotrienols sit in the lipid phase and intercept peroxyl radicals in the same chain reaction that tocopherol interrupts. That spares tocopherol for other work.

EPA shifts eicosanoid output toward less aggregatory thromboxane, and ginkgolides act as platelet activating factor antagonists. The two push normal platelet function in the same direction, so the effect adds up.

Garlic organosulfur compounds lower platelet aggregation by a route separate from the eicosanoid shift EPA produces. Combined, they add to the same change in normal platelet function.

Salicylate blocks thromboxane formation in the platelet, the same output EPA competes with as a substrate. Their effects on normal platelet function stack.

Omega-6 gamma-linolenic acid and the omega-3 chain use the same desaturase and elongase enzymes and compete for incorporation into membrane phospholipids. A large omega-6 dose alongside dilutes the omega-3 signature of the membrane.

Unbound iron drives Fenton chemistry that starts peroxidation of long-chain polyunsaturated fats. Co-dosing high iron with an unprotected oil favours rancidity chemistry in the gut.

Triglyceride-form oil has to be hydrolysed by lipase before the fatty acids can be absorbed. Added lipase supports that step when pancreatic output or bile flow is modest.

Fish oil is a mixture and EPA is one of its two active long-chain omega-3 fatty acids, so adding an EPA concentrate raises the same molecule the oil already delivers. This matters for dose accounting rather than for mechanism, and the total EPA plus DHA is the number that should be tracked. Concentrates change the ratio, which is how the eicosanoid profile shifts.

DHA is the structural omega-3 concentrated in retinal and neuronal membrane phospholipids, and standard fish oil supplies it alongside EPA. Adding a DHA-heavy oil raises the structural share without raising the eicosanoid-competing share as much. Total intake, not the number of bottles, is the figure that matters.

Linoleic acid and alpha-linolenic acid compete for the same delta-6 desaturase and elongase enzymes, and a high linoleic intake pushes that pathway toward arachidonic acid. Preformed EPA and DHA from fish oil bypass the bottleneck entirely, which is why the oil works even on a high omega-6 background. The competition is real at the enzyme, and its size in a whole diet is harder to pin down.

GLA elongates to dihomo-gamma-linolenic acid, which feeds series-1 eicosanoids, while EPA feeds the series-3 set; both draw on the same elongase capacity. Formulators combine them to occupy several branches of the pathway at once. High GLA alone can raise arachidonic acid over time, and co-dosed EPA is the usual counterweight.

Flaxseed supplies alpha-linolenic acid, the plant precursor that humans convert to EPA at a low and variable percentage and to DHA at a lower one still. Fish oil delivers the end products directly, so the two are not interchangeable on a gram basis. Together they cover both the precursor pool and the preformed supply.

Krill oil carries EPA and DHA largely bound to phospholipids rather than triglycerides, along with astaxanthin. Stacked with fish oil the omega-3 doses add up, so the combined total is what should be read against any intake target. The phospholipid carrier is a different delivery chemistry, not a different nutrient.

Long-chain polyunsaturated fatty acids have many double bonds and oxidise readily, so mixed tocopherols are added to the oil as a chain-breaking antioxidant during processing and storage. This protects the oil in the capsule, which is a stability function rather than a physiological one. Peroxide and anisidine values are the measures that show whether it worked.

Ascorbate regenerates the tocopheryl radical back to alpha-tocopherol at the lipid and water interface, which keeps the tocopherol pool that protects membrane polyunsaturated fatty acids working longer. The chemistry is settled; how much it changes lipid peroxidation markers at supplement doses varies between studies. This is a marker relationship, not a demonstrated clinical outcome.

Triglyceride and ethyl ester omega-3 forms both need pancreatic lipase to release the fatty acids before absorption, and ethyl esters are the slower substrate for that enzyme. Where pancreatic output is low, a lipase-containing enzyme blend addresses the rate-limiting step. Taking the oil with a fat-containing meal does much the same thing by triggering endogenous output.

Bile salts emulsify dietary fat into micelles so lipase can act and the products can cross the brush border. Without adequate bile flow, omega-3 absorption drops regardless of how the oil is esterified. Supplemental bile salts are used where flow is limited, and are not needed by someone with normal digestion.

Medium-chain triglycerides are absorbed by a partly bile-independent route and are commonly used as a carrier that keeps a long-chain oil dissolved and moving. As a co-ingested fat they also trigger bile and lipase release, which helps the omega-3 fraction. MCTs do not themselves supply EPA or DHA.

Phosphatidylcholine is an amphiphile that emulsifies triglyceride oil into finer droplets, raising the surface area available to lipase. It is used in liquid and emulsion omega-3 formats for exactly that reason, and it contributes choline of its own. The improvement is to dispersion, which is a step before absorption rather than absorption itself.

Lecithin from sunflower is a soy-free phospholipid emulsifier used to stabilise omega-3 emulsions and chewables. It keeps the oil phase dispersed so the dose stays uniform through a bottle. Its role is physical stability, not added omega-3.

Vitamin K is the cofactor for gamma-carboxylation of clotting factors, while high-dose EPA and DHA lengthen bleeding time by shifting platelet eicosanoid production. The two act on the same system from opposite directions. Anyone whose clotting is being monitored should have both intakes known rather than either changed quietly.

Nattokinase has fibrinolytic activity and omega-3 fatty acids reduce thromboxane-driven platelet aggregation. Stacked, the effects on bleeding tendency add rather than cancel. This is a combination to disclose to whoever monitors clotting, not one to assemble quietly.

Gingerols inhibit thromboxane synthesis, the same eicosanoid branch that EPA competes with at cyclooxygenase. The direction of the combination is additive on platelet aggregation measures. The size of the effect at culinary or ordinary supplement doses is small and not well quantified.

Garlic organosulfur compounds reduce platelet aggregation in laboratory and human marker studies, and omega-3 fatty acids do the same by a different route. Together the bleeding-time signal is additive. Worth flagging around scheduled procedures.

Curcumin inhibits cyclooxygenase and lipoxygenase signalling, and EPA competes with arachidonic acid as the substrate those enzymes see. The two act at the same pathway from substrate and enzyme sides. Both also carry a mild platelet effect that adds when they are stacked.

Niacin at pharmacological doses reduces hepatic VLDL output, and omega-3 fatty acids lower hepatic triglyceride synthesis and raise fatty acid oxidation. Both are measured against circulating triglycerides, a marker. Flushing-dose niacin belongs with a clinician who is watching those numbers rather than in a self-assembled stack.

Red yeast rice supplies monacolin K, which inhibits cholesterol synthesis, while fish oil acts mainly on triglyceride handling. The two move different lipid fractions, which is why they appear together in lipid-focused formulas. Monacolin content is a drug-identical molecule and its use belongs under clinical supervision.

Berberine acts through AMPK signalling on hepatic lipid and glucose handling; omega-3 fatty acids act on triglyceride synthesis and membrane composition. Their effects on lipid markers are additive in direction. Berberine also inhibits several drug-metabolising enzymes, which is the more important thing to check before stacking anything with it.

Psyllium raises the viscosity of gut contents and binds bile acids, which reduces the efficiency of fat absorption from the same meal. Taken in the same window it can lower how much of an omega-3 dose is absorbed. Separating the fibre and the oil by an hour or two avoids the overlap while keeping both.

Activated charcoal adsorbs lipophilic molecules in the gut lumen without discriminating between them. Co-dosed with an oil, it reduces what is absorbed. Dose them hours apart rather than together.